Sunil R. Lakhani

Signatures of mutational processes in human cancer

Landscape of somatic mutations in 560 breast cancer whole-genome sequences

The landscape of cancer genes and mutational processes in breast cancer

Adjuvant Olaparib for Patients with <i>BRCA1</i> - or <i>BRCA2</i> -Mutated Breast Cancer

Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update

WHO classification of tumours of the breast

Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth

HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures

The 2019 World Health Organization classification of tumours of the breast

Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)

Breast cancer prognostic classification in the molecular era: the role of histological grade

The Pathology of Familial Breast Cancer: Predictive Value of Immunohistochemical Markers Estrogen Receptor, Progesterone Receptor, HER-2, and p53 in Patients With Mutations in <i>BRCA1</i> and <i>BRCA2</i>